Tuesday, June 14, 2011

A bioprocessing facilities conference

The BioProcessing Facilities 2011 Conference
Aug. 8-9, 2011 (Early registration discount ends July 8)
San Diego, California

NOTE: This notice may not have reached all the right people in your organization -- please forward this to those in your organization and professional network who would have interest in this program.

The full conference program is now available online at: http://www.TradelineInc.com/BioProcessingAgenda
For a printable copy, download here (1MB pdf): http://www.TradelineInc.com/BioProcessingProgram

Many colleges and universities are formulating new plans for facilities and labs for the development and production of biologics for regenerative medicine, vaccines, cancer treatment, gene therapy, personalized medicine, and other treatments.

These projects (renovations, conversions, and expansions ranging from the lab benchtop to production) involve a whole new set of requirements for building infrastructure, people flow, mechanical systems, water purity, waste treatment, sterilization, scientific and production equipment, safety and security, and operational cost.

This conference is THE opportunity for your team to get the critical details, lessons learned, and insights for putting in place the right bioprocessing facility infrastructure with the right capital budget and operating cost model.

There are 21 information-packed sessions at this conference. Here are just five:


1. University of California Davis, Medical Center Stem Cell Program: The Institute for Regenerative Cures – a multi-use GMP facility with switchable room pressurization from a cellular manufacturing setting to a containment setting for FACS sorting or gene therapy vector production

2. The 155,000-square-foot Texas A&M National Center for Therapeutics Manufacturing (NCTM) – which has the capacity for developing and producing multiple biological products using multiple production technologies utilizing modular and disposable technologies

3. Fraunhofer USA – one of the first fully automated, scalable plant-based vaccine manufacturing facilities

4. The Advanced Technology Research Facility (ATRF) – the new collaborative biopharmaceutical process development and clinical manufacturing operation at the National Cancer Institute (NCI)-Frederick

5. Statens Serum Institute of Copenhagen, Denmark – an international research production and service enterprise involved in vaccine and biologic development


Gather your team and register today! For more conference details, visit: http://www.TradelineInc.com/BioProcessing2011.

If you have any further questions, do not hesitate to contact us at (925) 254-1744, ext. 19 or registrar@tradelineinc.com

I look forward to seeing you in August in San Diego!

Cordially,
Steve
Steve Westfall, Ph.D.
President
Tradeline, Inc.

No comments:

Post a Comment